On the other hand, research indicates that activation of FXR with an agonist can protect against atherosclerosis in LDLR-/- and ApoE-/- mice, which may be associated with suppression of genes involved in BAs synthesis (Hartman et al., 2009). The gene discussed is NR1H4; the disease is atherosclerosis.